| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 1 | 43 | ₹14,878 |
| HNI / NII | 14 | 602 | ₹2,08,292 |
| bHNI / bNII | 68 | 2,924 | ₹10,11,704 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 1,21,42,580 (50.00%) | — | ₹42,013.33 Cr |
| NII / HNI (Total) | — | 36,42,774 (15.00%) | — | ₹12,604.00 Cr |
| Retail Investors | — | 84,99,806 (35.00%) | — | ₹29,409.33 Cr |
| Total ** | — | 2,42,85,160 (100.00%) | — | ₹840,266.54 Cr |
| Metric | 30 Jun 2023 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Revenue | 184.60 | 744.94 | 702.88 |
| PAT | 44.12 | 160.03 | 181.59 |
| EBITDA | — | — | — |
| Net Worth | 725.68 | 681.49 | 521.54 |
| Total Assets | 903.80 | 862.07 | 713.38 |
| Reserves | 690.99 | 646.79 | 486.85 |
| Borrowings | — | — | — |
Incorporated in 1968, Blue Jet Healthcare is a pharmaceutical and healthcare ingredient and an intermediate company. Blue Jet Healthcare was the first manufacturer of saccharin and its salts (artificial sweeteners) in India. They later expanded into contrast media intermediates, which are used in CT scans and MRIs. The company mainly deals in three product categories: (i) contrast media intermediates, (ii) high-intensity sweeteners, and (iii) pharma intermediates and active pharmaceutical ingredients.
Blue Jet Healthcare is a global, science-led pharmaceutical company. They are the provider of:
The company has three manufacturing facilities, which are situated in Shahad (Unit I), Ambernath (Unit II) and Mahad (Unit III) in the state of Maharashtra, India, with an annual installed capacity of 200.60 KL, 607.30 KL and 213.00 KL, respectively, as of June 30, 2023.
Company's core strength lies in the following